17 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
23
Structure-Based Design of New LSD1/EGFRL858R/T790M Dual Inhibitors for Treating EGFR Mutant NSCLC Cancers.

Zhengzhou University
38
Combination Therapy and Dual-Target Inhibitors Based on LSD1: New Emerging Tools in Cancer Therapy.

Zhengzhou University
9
Dual inhibitors of HDAC and other epigenetic regulators: A novel strategy for cancer treatment.

Guru Ghasidas University
17
Design, synthesis, and structure-activity relationship of TAK-418 and its derivatives as a novel series of LSD1 inhibitors with lowered risk of hematological side effects.

Takeda Pharmaceutical
26
Structural and Functional Landscape of FAD-Dependent Histone Lysine Demethylases for New Drug Discovery.

Zhengzhou University
17
Research progress of dual inhibitors targeting crosstalk between histone epigenetic modulators for cancer therapy.

Xinxiang Medical University
6
Design, Synthesis, and Evaluation of [

Takeda Pharmaceutical
32
Reversible Lysine Specific Demethylase 1 (LSD1) Inhibitors: A Promising Wrench to Impair LSD1.

Zhengzhou University
47
Drug discovery of histone lysine demethylases (KDMs) inhibitors (progress from 2018 to present).

Hangzhou Normal University
36
Novel non-covalent LSD1 inhibitors endowed with anticancer effects in leukemia and solid tumor cellular models.

Sapienza University of Rome
11
Structure-Based Identification of Potent Lysine-Specific Demethylase 1 Inhibitor Peptides and Temporary Cyclization to Enhance Proteolytic Stability and Cell Growth-Inhibitory Activity.

Nagoya City University
36
Tranylcypromine Based Lysine-Specific Demethylase 1 Inhibitor: Summary and Perspective.

Key Laboratory of Henan Provinc
2
Aminotriazole and Aminotetrazole Inhibitors of LSD1 as Epigenetic Modulators.

Dart Neuroscience
14
Histone lysine specific demethylase 1 inhibitors.

Taipei Medical University
3
3,5-Diamino-1,2,4-triazoles as a novel scaffold for potent, reversible LSD1 (KDM1A) inhibitors.

Medical University of South Carolina
28
Further insights into the SAR of α-substituted cyclopropylamine derivatives as inhibitors of histone demethylase KDM1A.

University of Parma
5
Cyclic peptide inhibitors of lysine-specific demethylase 1 with improved potency identified by alanine scanning mutagenesis.

Medical University of South Carolina